-
STAT News – Biotech2 weeks agoSTAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path
Pfizer and Valneva’s Lyme disease vaccine cut cases by about 73% in a Phase 3 trial, but missed its primary statistical endpoint — setting up a...
-
STAT News – Biotech2 weeks agoMatch Day results show impact of federal immigration policy
Salutations from San Diego. This is Jonathan Wosen, West Coast biotech & life sciences reporter. We’ve got an outstanding lineup for you today, featuring a look...
-
STAT News – Biotech2 weeks agoSTAT+: Doctronic raises $40 million as race to apply AI in clinical care heats up
Earlier this year the startup Doctronic launched a provocative, first-in-the-nation experiment to renew drug prescriptions with a chatbot. Now it’s refilling its coffers with $40 million...
-
STAT News – Biotech2 weeks agoSTAT+: Insmed drug benefits patients with rare, bacterial lung disease, study shows
Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung disease improved respiratory symptoms and...
-
STAT News – Biotech2 weeks agoSTAT+: Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle
An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to newly released data. Though results appear...
-
STAT News – Biotech2 weeks agoSTAT+: Apogee Therapeutics data show long-acting eczema drug induced relief with less frequent injections
An experimental, long-acting treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used medicines but with less frequent injections, a...
-
STAT News – Biotech2 weeks agoHer son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey
Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of strep throat from...
-
STAT News – Biotech2 weeks agoOpinion: The AI push in health care is deepening medicine’s trust crisis
After OpenAI and Anthropic launched dedicated health care initiatives in January, a study published in February found that OpenAI’s ChatGPT Health had a 50% error rate, incorrectly recommending that care be delayed in emergency test cases...
-
STAT News – Biotech3 weeks agoSTAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
President Trump’s Medicare director said Thursday his team is considering a policy that would automatically enroll Medicare beneficiaries into Medicare Advantage plans, a controversial idea that...
-
STAT News – Biotech3 weeks agoSTAT+: Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
